Decision-making impairments in Parkinson's disease as a by-product of defective cost-benefit analysis and feedback processing.

Neurodegener Dis Manag

Biological & Experimental Psychology Group, School of Biological & Chemical Sciences, Queen Mary University of London, Mile End Road, London, E1 4NS, UK.

Published: April 2015

Studies examining decision-making in people with Parkinson's disease (PD) show impaired performance on a variety of tasks. However, there are also demonstrations that patients with PD can make optimal decisions just like healthy age-matched controls. We propose that the reason for these mixed findings is that PD does not produce a generalized impairment of decision-making, but rather affects sub-components of this process. In this review we evaluate this hypothesis by considering the empirical evidence examining decision-making in PD. We suggest that of the various stages of the decision-making process, the most affected in PD are (1) the cost-benefit analysis stage and (2) the outcome evaluation stage. We consider the implications of this proposal for research in this area.

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt.14.23DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
8
cost-benefit analysis
8
examining decision-making
8
decision-making
5
decision-making impairments
4
impairments parkinson's
4
disease by-product
4
by-product defective
4
defective cost-benefit
4
analysis feedback
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!